Answers are grounded in this paper and cite their sources.
Resurgence of Kala-Azar in India has posed many problems. Apart from patients from endemic areas, cases are being reported from non-endemic areas also. In the present series, four out of 26 patients were from non-endemic areas. Other than diagnostic difficulties, resistance to stibogluconate and relapse are common problems which were seen in eight patients. The clinical profile of cases, their management, and how the problem of resistance was tackled are described.
No takes yet. Share an insight, caveat, or question.
J et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: